APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepcidin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hepcidin Market Analysis and Forecast 2026-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchHepcidin Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepcidin Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Hepcidin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepcidin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepcidin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Hepcidin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hepcidin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hepcidin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hepcidin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hepcidin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Hepcidin include Protagonist Therapeutics Inc, Pieris Pharmaceuticals Inc, Noxxon Pharma AG and Daiichi Sankyo Co Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hepcidin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hepcidin, also provides the sales of main regions and countries. Of the upcoming market potential for Hepcidin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hepcidin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hepcidin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hepcidin sales, projected growth trends, production technology, application and end-user industry.

Hepcidin Segment by Company

Protagonist Therapeutics Inc

Pieris Pharmaceuticals Inc

Noxxon Pharma AG

Daiichi Sankyo Co Ltd

Hepcidin Segment by Type

PTG-300

PRS-080

M-009

DS-79182026

Others

Hepcidin Segment by Application

Acute Inflammation

Sickle Cell Disease

Anemia

Iron Deficiency Anemia

Others

Hepcidin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepcidin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepcidin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepcidin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hepcidin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hepcidin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepcidin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hepcidin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. PTG-300 Major Manufacturers Table 3. PRS-080 Major Manufacturers Table 4. M-009 Major Manufacturers Table 5. DS-79182026 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Hepcidin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Acute Inflammation Major Manufacturers Table 9. Sickle Cell Disease Major Manufacturers Table 10. Anemia Major Manufacturers Table 11. Iron Deficiency Anemia Major Manufacturers Table 12. Others Major Manufacturers Table 13. Hepcidin Industry Trends Table 14. Hepcidin Industry Drivers Table 15. Hepcidin Industry Opportunities and Challenges Table 16. Hepcidin Industry Restraints Table 17. Global Hepcidin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Hepcidin Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Hepcidin Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Hepcidin Revenue Market Share by Region (2021-2026) Table 21. Global Hepcidin Revenue Market Share by Region (2027-2032) Table 22. Global Hepcidin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 23. Global Hepcidin Sales by Region (2021-2026) & (k units) Table 24. Global Hepcidin Sales by Region (2027-2032) & (k units) Table 25. Global Hepcidin Sales Market Share by Region (2021-2026) Table 26. Global Hepcidin Sales Market Share by Region (2027-2032) Table 27. Global Hepcidin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Hepcidin Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Hepcidin Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Hepcidin Sales Market Share by Manufacturers (2021-2026) Table 31. Global Hepcidin Sales Price (US$/unit) of Manufacturers (2021-2026) Table 32. Global Hepcidin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Hepcidin Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Hepcidin Manufacturers, Product Type & Application Table 35. Global Hepcidin Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Hepcidin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Hepcidin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Hepcidin Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Hepcidin Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Hepcidin Revenue Market Share by Type (2021-2026) Table 42. Global Hepcidin Revenue Market Share by Type (2027-2032) Table 43. Global Hepcidin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 44. Global Hepcidin Sales by Type (2021-2026) & (k units) Table 45. Global Hepcidin Sales by Type (2027-2032) & (k units) Table 46. Global Hepcidin Sales Market Share by Type (2021-2026) Table 47. Global Hepcidin Sales Market Share by Type (2027-2032) Table 48. Global Hepcidin Price by Type (2021-2026) & (US$/unit) Table 49. Global Hepcidin Price by Type (2027-2032) & (US$/unit) Table 50. Global Hepcidin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Hepcidin Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Hepcidin Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Hepcidin Revenue Market Share by Application (2021-2026) Table 54. Global Hepcidin Revenue Market Share by Application (2027-2032) Table 55. Global Hepcidin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 56. Global Hepcidin Sales by Application (2021-2026) & (k units) Table 57. Global Hepcidin Sales by Application (2027-2032) & (k units) Table 58. Global Hepcidin Sales Market Share by Application (2021-2026) Table 59. Global Hepcidin Sales Market Share by Application (2027-2032) Table 60. Global Hepcidin Price by Application (2021-2026) & (US$/unit) Table 61. Global Hepcidin Price by Application (2027-2032) & (US$/unit) Table 62. Protagonist Therapeutics Inc Company Information Table 63. Protagonist Therapeutics Inc Business Overview Table 64. Protagonist Therapeutics Inc Hepcidin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Protagonist Therapeutics Inc Hepcidin Product Portfolio Table 66. Protagonist Therapeutics Inc Recent Development Table 67. Pieris Pharmaceuticals Inc Company Information Table 68. Pieris Pharmaceuticals Inc Business Overview Table 69. Pieris Pharmaceuticals Inc Hepcidin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Pieris Pharmaceuticals Inc Hepcidin Product Portfolio Table 71. Pieris Pharmaceuticals Inc Recent Development Table 72. Noxxon Pharma AG Company Information Table 73. Noxxon Pharma AG Business Overview Table 74. Noxxon Pharma AG Hepcidin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Noxxon Pharma AG Hepcidin Product Portfolio Table 76. Noxxon Pharma AG Recent Development Table 77. Daiichi Sankyo Co Ltd Company Information Table 78. Daiichi Sankyo Co Ltd Business Overview Table 79. Daiichi Sankyo Co Ltd Hepcidin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Daiichi Sankyo Co Ltd Hepcidin Product Portfolio Table 81. Daiichi Sankyo Co Ltd Recent Development Table 82. North America Hepcidin Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Hepcidin Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Hepcidin Sales by Type (2021-2026) & (k units) Table 85. North America Hepcidin Sales by Type (2027-2032) & (k units) Table 86. North America Hepcidin Sales Price by Type (2021-2026) & (US$/unit) Table 87. North America Hepcidin Sales Price by Type (2027-2032) & (US$/unit) Table 88. North America Hepcidin Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Hepcidin Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Hepcidin Sales by Application (2021-2026) & (k units) Table 91. North America Hepcidin Sales by Application (2027-2032) & (k units) Table 92. North America Hepcidin Sales Price by Application (2021-2026) & (US$/unit) Table 93. North America Hepcidin Sales Price by Application (2027-2032) & (US$/unit) Table 94. North America Hepcidin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Hepcidin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Hepcidin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Hepcidin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 98. North America Hepcidin Sales by Country (2021-2026) & (k units) Table 99. North America Hepcidin Sales by Country (2027-2032) & (k units) Table 100. North America Hepcidin Sales Price by Country (2021-2026) & (US$/unit) Table 101. North America Hepcidin Sales Price by Country (2027-2032) & (US$/unit) Table 102. United States Hepcidin Revenue (2021-2032) & (US$ Million) Table 103. Canada Hepcidin Revenue (2021-2032) & (US$ Million) Table 104. Mexico Hepcidin Revenue (2021-2032) & (US$ Million) Table 105. Europe Hepcidin Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Hepcidin Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Hepcidin Sales by Type (2021-2026) & (k units) Table 108. Europe Hepcidin Sales by Type (2027-2032) & (k units) Table 109. Europe Hepcidin Sales Price by Type (2021-2026) & (US$/unit) Table 110. Europe Hepcidin Sales Price by Type (2027-2032) & (US$/unit) Table 111. Europe Hepcidin Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Hepcidin Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Hepcidin Sales by Application (2021-2026) & (k units) Table 114. Europe Hepcidin Sales by Application (2027-2032) & (k units) Table 115. Europe Hepcidin Sales Price by Application (2021-2026) & (US$/unit) Table 116. Europe Hepcidin Sales Price by Application (2027-2032) & (US$/unit) Table 117. Europe Hepcidin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Hepcidin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Hepcidin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Hepcidin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 121. Europe Hepcidin Sales by Country (2021-2026) & (k units) Table 122. Europe Hepcidin Sales by Country (2027-2032) & (k units) Table 123. Europe Hepcidin Sales Price by Country (2021-2026) & (US$/unit) Table 124. Europe Hepcidin Sales Price by Country (2027-2032) & (US$/unit) Table 125. Germany Hepcidin Revenue (2021-2032) & (US$ Million) Table 126. France Hepcidin Revenue (2021-2032) & (US$ Million) Table 127. U.K. Hepcidin Revenue (2021-2032) & (US$ Million) Table 128. Italy Hepcidin Revenue (2021-2032) & (US$ Million) Table 129. Russia Hepcidin Revenue (2021-2032) & (US$ Million) Table 130. Spain Hepcidin Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Hepcidin Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Hepcidin Revenue (2021-2032) & (US$ Million) Table 133. Sweden Hepcidin Revenue (2021-2032) & (US$ Million) Table 134. Poland Hepcidin Revenue (2021-2032) & (US$ Million) Table 135. China Hepcidin Revenue by Type (2021-2026) & (US$ Million) Table 136. China Hepcidin Revenue by Type (2027-2032) & (US$ Million) Table 137. China Hepcidin Sales by Type (2021-2026) & (k units) Table 138. China Hepcidin Sales by Type (2027-2032) & (k units) Table 139. China Hepcidin Sales Price by Type (2021-2026) & (US$/unit) Table 140. China Hepcidin Sales Price by Type (2027-2032) & (US$/unit) Table 141. China Hepcidin Revenue by Application (2021-2026) & (US$ Million) Table 142. China Hepcidin Revenue by Application (2027-2032) & (US$ Million) Table 143. China Hepcidin Sales by Application (2021-2026) & (k units) Table 144. China Hepcidin Sales by Application (2027-2032) & (k units) Table 145. China Hepcidin Sales Price by Application (2021-2026) & (US$/unit) Table 146. China Hepcidin Sales Price by Application (2027-2032) & (US$/unit) Table 147. Asia Hepcidin Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Hepcidin Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Hepcidin Sales by Type (2021-2026) & (k units) Table 150. Asia Hepcidin Sales by Type (2027-2032) & (k units) Table 151. Asia Hepcidin Sales Price by Type (2021-2026) & (US$/unit) Table 152. Asia Hepcidin Sales Price by Type (2027-2032) & (US$/unit) Table 153. Asia Hepcidin Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Hepcidin Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Hepcidin Sales by Application (2021-2026) & (k units) Table 156. Asia Hepcidin Sales by Application (2027-2032) & (k units) Table 157. Asia Hepcidin Sales Price by Application (2021-2026) & (US$/unit) Table 158. Asia Hepcidin Sales Price by Application (2027-2032) & (US$/unit) Table 159. Asia Hepcidin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Hepcidin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Hepcidin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Hepcidin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 163. Asia Hepcidin Sales by Country (2021-2026) & (k units) Table 164. Asia Hepcidin Sales by Country (2027-2032) & (k units) Table 165. Asia Hepcidin Sales Price by Country (2021-2026) & (US$/unit) Table 166. Asia Hepcidin Sales Price by Country (2027-2032) & (US$/unit) Table 167. Japan Hepcidin Revenue (2021-2032) & (US$ Million) Table 168. South Korea Hepcidin Revenue (2021-2032) & (US$ Million) Table 169. India Hepcidin Revenue (2021-2032) & (US$ Million) Table 170. Australia Hepcidin Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Hepcidin Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Hepcidin Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Hepcidin Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Hepcidin Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Hepcidin Sales by Type (2021-2026) & (k units) Table 176. SAMEA Hepcidin Sales by Type (2027-2032) & (k units) Table 177. SAMEA Hepcidin Sales Price by Type (2021-2026) & (US$/unit) Table 178. SAMEA Hepcidin Sales Price by Type (2027-2032) & (US$/unit) Table 179. SAMEA Hepcidin Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Hepcidin Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Hepcidin Sales by Application (2021-2026) & (k units) Table 182. SAMEA Hepcidin Sales by Application (2027-2032) & (k units) Table 183. SAMEA Hepcidin Sales Price by Application (2021-2026) & (US$/unit) Table 184. SAMEA Hepcidin Sales Price by Application (2027-2032) & (US$/unit) Table 185. SAMEA Hepcidin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Hepcidin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Hepcidin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Hepcidin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 189. SAMEA Hepcidin Sales by Country (2021-2026) & (k units) Table 190. SAMEA Hepcidin Sales by Country (2027-2032) & (k units) Table 191. SAMEA Hepcidin Sales Price by Country (2021-2026) & (US$/unit) Table 192. SAMEA Hepcidin Sales Price by Country (2027-2032) & (US$/unit) Table 193. Brazil Hepcidin Revenue (2021-2032) & (US$ Million) Table 194. Argentina Hepcidin Revenue (2021-2032) & (US$ Million) Table 195. Chile Hepcidin Revenue (2021-2032) & (US$ Million) Table 196. Colombia Hepcidin Revenue (2021-2032) & (US$ Million) Table 197. Peru Hepcidin Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Hepcidin Revenue (2021-2032) & (US$ Million) Table 199. Israel Hepcidin Revenue (2021-2032) & (US$ Million) Table 200. UAE Hepcidin Revenue (2021-2032) & (US$ Million) Table 201. Turkey Hepcidin Revenue (2021-2032) & (US$ Million) Table 202. Iran Hepcidin Revenue (2021-2032) & (US$ Million) Table 203. Egypt Hepcidin Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Hepcidin Distributors List Table 207. Hepcidin Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Hepcidin Image Figure 2. Global Hepcidin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepcidin Market Size Share 2021 VS 2025 VS 2032 Figure 4. PTG-300 Image Figure 5. PRS-080 Image Figure 6. M-009 Image Figure 7. DS-79182026 Image Figure 8. Others Image Figure 9. Global Hepcidin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Hepcidin Market Size Share 2021 VS 2025 VS 2032 Figure 11. Acute Inflammation Image Figure 12. Sickle Cell Disease Image Figure 13. Anemia Image Figure 14. Iron Deficiency Anemia Image Figure 15. Others Image Figure 16. Global Hepcidin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Hepcidin Revenue (2021-2032) & (US$ Million) Figure 18. Global Hepcidin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Hepcidin Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Hepcidin Revenue Market Share by Region (2021-2032) Figure 21. Global Hepcidin Sales (2021-2032) & (k units) Figure 22. Global Hepcidin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 23. Global Hepcidin Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Hepcidin Sales YoY (2021-2032) & (k units) Figure 25. Europe Hepcidin Sales YoY (2021-2032) & (k units) Figure 26. China Hepcidin Sales YoY (2021-2032) & (k units) Figure 27. Asia (Excluding China) Hepcidin Sales YoY (2021-2032) & (k units) Figure 28. South America, Middle East and Africa Hepcidin Sales YoY (2021-2032) & (k units) Figure 29. Global Hepcidin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Hepcidin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Hepcidin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Hepcidin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Hepcidin Revenue Market Share by Type (2021-2032) Figure 35. Global Hepcidin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Hepcidin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Hepcidin Sales Market Share by Type (2021-2032) Figure 38. Global Hepcidin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Hepcidin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Hepcidin Revenue Market Share by Application (2021-2032) Figure 41. Global Hepcidin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 42. Global Hepcidin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Hepcidin Sales Market Share by Application (2021-2032) Figure 44. North America Hepcidin Revenue Share by Type (2021-2032) Figure 45. North America Hepcidin Sales Share by Type (2021-2032) Figure 46. North America Hepcidin Revenue Share by Application (2021-2032) Figure 47. North America Hepcidin Sales Share by Application (2021-2032) Figure 48. North America Hepcidin Revenue Share by Country (2021-2032) Figure 49. North America Hepcidin Sales Share by Country (2021-2032) Figure 50. Europe Hepcidin Revenue Share by Type (2021-2032) Figure 51. Europe Hepcidin Sales Share by Type (2021-2032) Figure 52. Europe Hepcidin Revenue Share by Application (2021-2032) Figure 53. Europe Hepcidin Sales Share by Application (2021-2032) Figure 54. Europe Hepcidin Revenue Share by Country (2021-2032) Figure 55. Europe Hepcidin Sales Share by Country (2021-2032) Figure 56. China Hepcidin Revenue Share by Type (2021-2032) Figure 57. China Hepcidin Sales Share by Type (2021-2032) Figure 58. China Hepcidin Revenue Share by Application (2021-2032) Figure 59. China Hepcidin Sales Share by Application (2021-2032) Figure 60. Asia Hepcidin Revenue Share by Type (2021-2032) Figure 61. Asia Hepcidin Sales Share by Type (2021-2032) Figure 62. Asia Hepcidin Revenue Share by Application (2021-2032) Figure 63. Asia Hepcidin Sales Share by Application (2021-2032) Figure 64. Asia Hepcidin Revenue Share by Country (2021-2032) Figure 65. Asia Hepcidin Sales Share by Country (2021-2032) Figure 66. SAMEA Hepcidin Revenue Share by Type (2021-2032) Figure 67. SAMEA Hepcidin Sales Share by Type (2021-2032) Figure 68. SAMEA Hepcidin Revenue Share by Application (2021-2032) Figure 69. SAMEA Hepcidin Sales Share by Application (2021-2032) Figure 70. SAMEA Hepcidin Revenue Share by Country (2021-2032) Figure 71. SAMEA Hepcidin Sales Share by Country (2021-2032) Figure 72. Hepcidin Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Hepcidin Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • PTG-300
  • PRS-080
  • M-009
  • DS-79182026
  • Others
Applications
  • Acute Inflammation
  • Sickle Cell Disease
  • Anemia
  • Iron Deficiency Anemia
  • Others
Companies covered
  • Protagonist Therapeutics Inc
  • Pieris Pharmaceuticals Inc
  • Noxxon Pharma AG
  • Daiichi Sankyo Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hepcidin Market by Type
  3. 1.2.1 Global Hepcidin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 PTG-300
  5. 1.2.3 PRS-080
  6. 1.2.4 M-009
  7. 1.2.5 DS-79182026
  8. 1.2.6 Others
  9. 1.3 Hepcidin Market by Application
  10. 1.3.1 Global Hepcidin Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Acute Inflammation
  12. 1.3.3 Sickle Cell Disease
  13. 1.3.4 Anemia
  14. 1.3.5 Iron Deficiency Anemia
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Hepcidin Market Dynamics
  1. 2.1 Hepcidin Industry Trends
  2. 2.2 Hepcidin Industry Drivers
  3. 2.3 Hepcidin Industry Opportunities and Challenges
  4. 2.4 Hepcidin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hepcidin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hepcidin Revenue by Region
  3. 3.2.1 Global Hepcidin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hepcidin Revenue by Region (2021-2026)
  5. 3.2.3 Global Hepcidin Revenue by Region (2027-2032)
  6. 3.2.4 Global Hepcidin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hepcidin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hepcidin Sales by Region
  9. 3.4.1 Global Hepcidin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hepcidin Sales by Region (2021-2026)
  11. 3.4.3 Global Hepcidin Sales by Region (2027-2032)
  12. 3.4.4 Global Hepcidin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hepcidin Revenue by Manufacturers
  2. 4.1.1 Global Hepcidin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hepcidin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hepcidin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hepcidin Sales by Manufacturers
  6. 4.2.1 Global Hepcidin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hepcidin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hepcidin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hepcidin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hepcidin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hepcidin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hepcidin Manufacturers, Product Type & Application
  13. 4.7 Global Hepcidin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hepcidin Market CR5 and HHI
  16. 4.8.2 2025 Hepcidin Tier 1, Tier 2, and Tier 3
5 Hepcidin Market by Type
  1. 5.1 Global Hepcidin Revenue by Type
  2. 5.1.1 Global Hepcidin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hepcidin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hepcidin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hepcidin Sales by Type
  6. 5.2.1 Global Hepcidin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hepcidin Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Hepcidin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hepcidin Price by Type
6 Hepcidin Market by Application
  1. 6.1 Global Hepcidin Revenue by Application
  2. 6.1.1 Global Hepcidin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hepcidin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hepcidin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hepcidin Sales by Application
  6. 6.2.1 Global Hepcidin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hepcidin Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Hepcidin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hepcidin Price by Application
7 Company Profiles
  1. 7.1 Protagonist Therapeutics Inc
  2. 7.1.1 Protagonist Therapeutics Inc Company Information
  3. 7.1.2 Protagonist Therapeutics Inc Business Overview
  4. 7.1.3 Protagonist Therapeutics Inc Hepcidin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Protagonist Therapeutics Inc Hepcidin Product Portfolio
  6. 7.1.5 Protagonist Therapeutics Inc Recent Developments
  7. 7.2 Pieris Pharmaceuticals Inc
  8. 7.2.1 Pieris Pharmaceuticals Inc Company Information
  9. 7.2.2 Pieris Pharmaceuticals Inc Business Overview
  10. 7.2.3 Pieris Pharmaceuticals Inc Hepcidin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pieris Pharmaceuticals Inc Hepcidin Product Portfolio
  12. 7.2.5 Pieris Pharmaceuticals Inc Recent Developments
  13. 7.3 Noxxon Pharma AG
  14. 7.3.1 Noxxon Pharma AG Company Information
  15. 7.3.2 Noxxon Pharma AG Business Overview
  16. 7.3.3 Noxxon Pharma AG Hepcidin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Noxxon Pharma AG Hepcidin Product Portfolio
  18. 7.3.5 Noxxon Pharma AG Recent Developments
  19. 7.4 Daiichi Sankyo Co Ltd
  20. 7.4.1 Daiichi Sankyo Co Ltd Company Information
  21. 7.4.2 Daiichi Sankyo Co Ltd Business Overview
  22. 7.4.3 Daiichi Sankyo Co Ltd Hepcidin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Daiichi Sankyo Co Ltd Hepcidin Product Portfolio
  24. 7.4.5 Daiichi Sankyo Co Ltd Recent Developments
8 North America
  1. 8.1 North America Hepcidin Market Size by Type
  2. 8.1.1 North America Hepcidin Revenue by Type (2021-2032)
  3. 8.1.2 North America Hepcidin Sales by Type (2021-2032)
  4. 8.1.3 North America Hepcidin Price by Type (2021-2032)
  5. 8.2 North America Hepcidin Market Size by Application
  6. 8.2.1 North America Hepcidin Revenue by Application (2021-2032)
  7. 8.2.2 North America Hepcidin Sales by Application (2021-2032)
  8. 8.2.3 North America Hepcidin Price by Application (2021-2032)
  9. 8.3 North America Hepcidin Market Size by Country
  10. 8.3.1 North America Hepcidin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hepcidin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hepcidin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Hepcidin Market Size by Type
  2. 9.1.1 Europe Hepcidin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hepcidin Sales by Type (2021-2032)
  4. 9.1.3 Europe Hepcidin Price by Type (2021-2032)
  5. 9.2 Europe Hepcidin Market Size by Application
  6. 9.2.1 Europe Hepcidin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hepcidin Sales by Application (2021-2032)
  8. 9.2.3 Europe Hepcidin Price by Application (2021-2032)
  9. 9.3 Europe Hepcidin Market Size by Country
  10. 9.3.1 Europe Hepcidin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hepcidin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hepcidin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Hepcidin Market Size by Type
  2. 10.1.1 China Hepcidin Revenue by Type (2021-2032)
  3. 10.1.2 China Hepcidin Sales by Type (2021-2032)
  4. 10.1.3 China Hepcidin Price by Type (2021-2032)
  5. 10.2 China Hepcidin Market Size by Application
  6. 10.2.1 China Hepcidin Revenue by Application (2021-2032)
  7. 10.2.2 China Hepcidin Sales by Application (2021-2032)
  8. 10.2.3 China Hepcidin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hepcidin Market Size by Type
  2. 11.1.1 Asia Hepcidin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hepcidin Sales by Type (2021-2032)
  4. 11.1.3 Asia Hepcidin Price by Type (2021-2032)
  5. 11.2 Asia Hepcidin Market Size by Application
  6. 11.2.1 Asia Hepcidin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hepcidin Sales by Application (2021-2032)
  8. 11.2.3 Asia Hepcidin Price by Application (2021-2032)
  9. 11.3 Asia Hepcidin Market Size by Country
  10. 11.3.1 Asia Hepcidin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hepcidin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hepcidin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hepcidin Market Size by Type
  2. 12.1.1 SAMEA Hepcidin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hepcidin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hepcidin Price by Type (2021-2032)
  5. 12.2 SAMEA Hepcidin Market Size by Application
  6. 12.2.1 SAMEA Hepcidin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hepcidin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hepcidin Price by Application (2021-2032)
  9. 12.3 SAMEA Hepcidin Market Size by Country
  10. 12.3.1 SAMEA Hepcidin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hepcidin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hepcidin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hepcidin Value Chain Analysis
  2. 13.1.1 Hepcidin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hepcidin Production Mode & Process
  6. 13.2 Hepcidin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hepcidin Distributors
  9. 13.2.3 Hepcidin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst